Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2070PDF: 1522HTML: 248 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
973PDF: 891Suppl. Files: 577HTML: 73 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1536PDF: 766HTML: 839jdoe, table 2 infections CML .doc: 174jdoe, table 1 infections CML .doc: 160 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2432PDF: 815HTML: 8787Efremov 1: 204Efremov 2: 164 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
1951PDF: 611HTML: 241 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1221HTML: 281PDF: 894Suppl. Files: 431 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
1988PDF: 906HTML: 125Suppl. Files: 490 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2730PDF: 1080HTML: 11204 -
-
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1903PDF: 1345HTML: 246 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1983PDF: 900HTML: 278 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3664PDF: 1411HTML: 458Figures . Eliassian: 203 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3735Suppl. Files: 1043PDF: 1017Html: 106 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3023PDF: 1766HTML: 3540 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1200PDF: 450HTML: 18540Figure 1: 151Figure 2: 137Figure 3: 153Figure 4: 185Figure 5: 156 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1976PDF: 1593HTML: 344 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
551PDF: 270Suppl. Files: 102HTML: 93 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3226PDF: 1429HTML: 3972 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
1964PDF: 745HTML: 2298Untitled: 197 -
ADVANCES IN THE TREATMENT OF MALARIA
2776PDF: 1089HTML: 5976 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3409PDF: 848HTML: 1620figure 1: 148Untitled: 172 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
890PDF: 441HTML: 63 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1312PDF: 729HTML: 930 -







